Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20200044 06.06.2020
Status
Published
(180) Expiration Date
(20) Filing Number and Date
BN N/2020/0044 13.12.2018
(40) Publication Number and Date
BN N/2020/0044
A
06.06.2020
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/595,842
07.12.2017
(72) Inventor
(EN) RYAN, Michael, S.
(EN) MARTIN, Sherrie-Ann, P.
(EN) JONES, Morrisa
(EN) STANBRO, Justin
(EN) BHAMBHANI, Akhilesh
(EN) BLUE, Jeffrey Thomas
(EN) PIXLEY, Heidi Joanne
(EN) GREEN-TREXLER, Erin, J.
(EN) ISOPI, Lynne Ann
(74) Representative Name
(EN) m/s Spruson & Ferguson Pte Ltd : C/O AIP Law Unit 404A-410A, 4th Floor, Wisma Jaya, Jalan Pemancha, Bandar Seri Begawan BS8811,
(54) Title
(EN) FORMULATIONS OF DENGUE VIRUS VACCINE COMPOSITIONS
(57) Abstract
(EN)
The present invention relates to formulations of dengue virus vaccine comprising at least one live attenuated dengue virus or live attenuated chimeric flavivirus, a buffer, a sugar, a cellulose derivative, a glycol or sugar alcohol, optionally an alkali or alkaline salt and an amino acid; and formulations of dengue virus vaccine comprising at least one live attenuated dengue virus or live attenuated chimeric flavivirus, a buffer, a sugar of at least 150 mg/ml, a carrier, and optionally an alkali or alkaline salt and an amino acid.
(58) Citations